⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for imatinib mesylate (gleevec)

Every month we try and update this database with for imatinib mesylate (gleevec) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GISTNCT00500188
Gastrointestina...
Imatinib Mesyla...
- M.D. Anderson Cancer Center
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateNCT00038675
Chronic Myelomo...
Chronic Myeloid...
Polycythemia Ve...
Hypereosinophil...
Mastocytosis
Imatinib Mesyla...
- M.D. Anderson Cancer Center
PTK 787 and Gleevec in Patients With AML, AMM, and CML-BPNCT00088231
Acute Myelogeno...
Agnogenic Myelo...
Chronic Myeloge...
Imatinib Mesyla...
PTK 787 (vatala...
15 Years - M.D. Anderson Cancer Center
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib MesylateNCT00038675
Chronic Myelomo...
Chronic Myeloid...
Polycythemia Ve...
Hypereosinophil...
Mastocytosis
Imatinib Mesyla...
- M.D. Anderson Cancer Center
Study of Lonafarnib and Gleevec in Chronic Myelogenous LeukemiaNCT00047502
Chronic Myeloge...
Lonafarnib (SCH...
Imatinib Mesyla...
16 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: